Abstract:Protein kinase RNA‐like ER kinase (PERK) is an endoplasmic reticulum (ER) stress sensor that responds to the accumulation of misfolded proteins. Once activated, PERK initiates signalling pathways that halt general protein production, increase the efficiency of ER quality control, and maintain redox homeostasis. PERK activation also protects mitochondrial homeostasis during stress. The location of PERK at the contact sites between the ER and the mitochondria creates a PERK–mitochondria axis that allows PERK to detect stress in both organelles, adapt their functions and prevent apoptosis. During ER stress, PERK activation triggers mitochondrial hyperfusion, preventing premature apoptotic fragmentation of the mitochondria. PERK activation also increases the formation of mitochondrial cristae and the assembly of respiratory supercomplexes, enhancing cellular ATP‐generating capacity. PERK strengthens mitochondrial quality control during stress by promoting the expression of mitochondrial chaperones and proteases and by increasing mitochondrial biogenesis and mitophagy, resulting in renewal of the mitochondrial network. But how does PERK mediate all these changes in mitochondrial homeostasis? In addition to the classic PERK–eukaryotic translation initiation factor 2α (eIF2α)–activating transcription factor 4 (ATF4) pathway, PERK can activate other protective pathways – PERK–O‐linked N‐acetyl‐glucosamine transferase (OGT), PERK–transcription factor EB (TFEB), and PERK–nuclear factor erythroid 2‐related factor 2 (NRF2) – contributing to broader regulation of mitochondrial dynamics, metabolism, and quality control. The pharmacological activation of PERK is protective in models of neurodegenerative and metabolic diseases, such as Huntington's disease, progressive supranuclear palsy and obesity, while the inhibition of PERK was protective in models of Parkinson's and prion diseases and diabetes. In this review, we address the molecular mechanisms by which PERK regulates mitochondrial dynamics, metabolism and quality control, and discuss the therapeutic potential of targeting PERK in neurodegenerative and metabolic diseases.

UPRmt and Coordinated UPRER in Type 2 Diabetes

The mitochondrial unfolded protein response: A multitasking giant in the fight against human diseases

Mitochondrial Unfolded Protein Response and Its Roles in Stem Cells.

Mitochondrial unfolded protein response (mtUPR) and diseases

Endoplasmic Reticulum Stress and Metabolic Dysfunction

Dual roles of UPRer and UPRmt in neurodegenerative diseases

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Research Advancement of Unfolded Protein Response in Endoplasmic Reticulum of Insulin Resistance and Exercise Stress

Endoplasmic reticulum-unfolded protein response pathway modulates the cellular response to mitochondrial proteotoxic stress

The unfolded protein response and diabetic retinopathy

The unfolded protein response: controlling cell fate decisions under ER stress and beyond

Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence

Mitochondrial Unfolded Protein Response and Integrated Stress Response as Promising Therapeutic Targets for Mitochondrial Diseases

Mitochondria-Associated Endoplasmic Reticulum Membranes In The Pathogenesis Of Type 2 Diabetes Mellitus

The translational content and expression of intracellular sensors under endoplasmic re-ticulum stress in diabetic rats

The impact of the unfolded protein response on human disease

The PERKs of mitochondria protection during stress: insights for PERK modulation in neurodegenerative and metabolic diseases

Current Status of Endoplasmic Reticulum Stress in Type II Diabetes

Living Dangerously: Protective and Harmful ER Stress Responses in Pancreatic β-Cells

Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy.

Mitochondrial Unfolded Protein Response: A Novel Pathway in Metabolism and Immunity